Literature DB >> 34437983

Visualizing and quantifying antimicrobial drug distribution in tissue.

Benjamin A Kuzma1, Isaac J Pence1, Daniel A Greenfield1, Alexander Ho1, Conor L Evans2.   

Abstract

The biodistribution and pharmacokinetics of drugs are vital to the mechanistic understanding of their efficacy. Measuring antimicrobial drug efficacy has been challenging as plasma drug concentration is used as a surrogate for tissue drug concentration, yet typically does not reflect that at the intended site(s) of action. Utilizing an image-guided approach, it is feasible to accurately quantify the biodistribution and pharmacokinetics within the desired site(s) of action. We outline imaging modalities used in visualizing drug distribution with examples ranging from in vitro cellular drug uptake to clinical treatment of microbial infections. The imaging modalities of interest are: radio-labeling, magnetic resonance, mass spectrometry imaging, computed tomography, fluorescence, and Raman spectroscopy. We outline the progress, limitations, and future outlook for each methodology. Further advances in these optical approaches would benefit patients and researchers alike, as non-invasive imaging could yield more profound insights with a lower clinical burden than invasive measurement approaches used today.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antimicrobials; Biodistribution; CT; Fluorescence; MRI; Mass spectrometry; PET; Pharmacokinetics; Raman; SPECT

Mesh:

Substances:

Year:  2021        PMID: 34437983     DOI: 10.1016/j.addr.2021.113942

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  1 in total

1.  Mass spectrometry imaging: new eyes on natural products for drug research and development.

Authors:  Jin-Jun Hou; Zi-Jia Zhang; Wen-Yong Wu; Qing-Qing He; Teng-Qian Zhang; Ya-Wen Liu; Zhao-Jun Wang; Lei Gao; Hua-Li Long; Min Lei; Wan-Ying Wu; De-An Guo
Journal:  Acta Pharmacol Sin       Date:  2022-10-13       Impact factor: 7.169

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.